Home › Funds › Nan Fung Group Holdings Ltd › BOLT

Nan Fung Group Holdings Ltd position in BOLT

Bolt Biotherapeutics · Health Care

Nan Fung Group Holdings Ltd reported holding 5,000 shares of BOLT (Bolt Biotherapeutics) in its Q3 2026 13F filing — a position valued at US$18K, representing 0.01% of its reported portfolio and ranking #28 among its reported holdings. Nan Fung Group Holdings Ltd has disclosed BOLT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)5.00K sh
Reported value held$18.40K
Portfolio Weight0.01%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nan Fung Group Holdings Ltd's BOLT position evolved

Nan Fung Group Holdings Ltd first disclosed a stake in BOLT in Q3 2023 at 1,166,952 shares (US$1.2M). The position peaked in Q1 2024 at 1,166,952 shares, worth US$1.6M. Across 13 filings, Nan Fung Group Holdings Ltd increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 5,000 shares valued at US$18K. Notable position changes include a 95% trim in Q2 2025 (shares fell 8% over the following quarter), a 50% trim in Q1 2026 (shares fell 5% over the following quarter), a 83% trim in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.17M $1.21M New
Q4 2023 1.17M $1.31M Hold
Q1 2024 1.17M $1.63M Hold
Q2 2024 1.17M $875.21K Hold
Q3 2024 1.17M $756.18K Hold
Q4 2024 1.17M $624.44K Hold
Q1 2025 1.17M $466.78K Hold
Q2 2025 58.35K $336.66K Reduce
Q3 2025 58.35K $310.41K Hold
Q4 2025 58.35K $319.04K Hold
Q1 2026 29.25K $118.17K Reduce
Q2 2026 5.00K $19.25K Reduce
Q3 2026 5.00K $18.40K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BOLT and 13F data

BOLT (Bolt Biotherapeutics) is a Health Care company. 16 other funds we track also report a position in BOLT — the largest reported positions include Vivo Capital, LLC (US$266K), Board of Trustees of The Leland Stanford Junior University (US$139K), Lynx1 Capital Management LP (US$119K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BOLT

All BOLT fund holders →

FAQ

How long has Nan Fung Group Holdings Ltd held BOLT?

Nan Fung Group Holdings Ltd has disclosed BOLT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nan Fung Group Holdings Ltd's current position in BOLT?

As of Q3 2026, Nan Fung Group Holdings Ltd holds 5.00K shares of BOLT (Bolt Biotherapeutics), valued at $18.40K, representing 0.01% of its reported portfolio and ranking #28.

Has Nan Fung Group Holdings Ltd been buying or selling BOLT?

In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd held unchanged its position in BOLT. The position peaked in Q1 2024 at 1.17M shares.

Which other funds hold BOLT?

Other major institutional holders of BOLT include Vivo Capital, LLC, Board of Trustees of The Leland Stanford Junior University, Lynx1 Capital Management LP, among 16 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.